SCHEMBL7367792

SCHEMBL7367792

CC(=O)c1ccc(-c2ccccc2)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
S100A4 P26447 1/20 0.50
SRD5A2 P31213 2/20 0.49
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CSNK2A1 P68400 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
PRKAB2 O43741 1/20 0.46
PRKAG1 P54619 1/20 0.46
PRKAA2 P54646 1/20 0.46
PRKAA1 Q13131 1/20 0.46
PRKAG3 Q9UGI9 1/20 0.46
PRKAG2 Q9UGJ0 1/20 0.46
PRKAB1 Q9Y478 1/20 0.46
HSD17B1 P14061 3/20 0.45
HSD17B2 P37059 1/20 0.45
CYP2A6 P11509 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11585221 0.89 HSD17B1 (0.54) MAPTSMN1; SMN2S100A4SRD5A2ALDH1A1
SCHEMBL29140064 0.85 SRD5A2 (0.60) MAPTSMN1; SMN2SRD5A2ALDH1A1KDM4E
SCHEMBL2044221 0.85 SRD5A2 (0.60) SRD5A2ALDH1A1CSNK2A1PRKAB2PRKAG1
SCHEMBL6207095 0.84 SRD5A2 (0.50) SRD5A2ALDH1A1KDM4EL3MBTL1CSNK2A1
SCHEMBL25598320 0.83 CNR2 (0.51) MAPTS100A4ALDH1A1KDM4EL3MBTL1
SCHEMBL14176467 0.83 MAPT (0.61) MAPTSMN1; SMN2S100A4ALDH1A1KDM4E
SCHEMBL6139775 0.83 PTGS1 (0.51) MAPTSMN1; SMN2S100A4SRD5A2ALDH1A1
SCHEMBL11801781 0.82 SRD5A2 (0.43) MAPTSMN1; SMN2SRD5A2ALDH1A1KDM4E
SCHEMBL11801774 0.82 SRD5A2 (0.43) MAPTSMN1; SMN2SRD5A2ALDH1A1KDM4E
SCHEMBL11801787 0.82 SRD5A2 (0.43) MAPTSMN1; SMN2SRD5A2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344464-B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination SANOFI-SYNTHELABO (FR) 2002-02-05 US disclosed
US-6342505-B1 inhibiting apoptosis using xaliproden hydrochloride, or other tetrahydropyridine derivatives SANOFI-SYNTHELABO (FR) 2002-01-29 US disclosed
US-4301313-A ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANALGESICS ELI-LILLY AND COMPANY (US) 1981-11-17 US disclosed
US-4267388-A BY SULFONATING A BENZYL ALCOHOL COMPOUND, REDUCING THE SULFONYL DERIVATIVE TO A HALOSTYRENYL COMPOUND, AND DEHYDROHALOGENATING TO THE ETHYNYLBENZENE WILLIAM H. RORER, INC. (US) 1981-05-12 US disclosed
US-4226887-A P-BIPHENYLYLACETYLENE ELI LILLY AND COMPANY (US) 1980-10-07 US disclosed
US-3991212-A PHENYLACETYLENE COMPOUNDS ELI LILLY AND COMPANY (US) 1976-11-09 US disclosed
US-3968251-A Arylacetylene compounds as antithrombotic agents ELI LILLY AND COMPANY (US) 1976-07-06 US disclosed
US-3950427-A ANTIINFLAMMATORY, ANTIPYRETIC BOEHRINGER INGELHEIM GMBH (DT) 1976-04-13 US disclosed
US-3939278-A Phenoxyphenyl-acetylenes and thio analogues thereof as antithrombotic agents ELI LILLY AND COMPANY (US) 1976-02-17 US disclosed